Advertisement
CLSK vs STEX
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLSK is a Hold and STEX is a Hold.
CLSK in downward trend: price dove below 50-day moving average on September 30, 2026
CLSK moved below its 50-day moving average on September 30, 2026 date and that indicates a change from an upward trend to a downward trend. In 32 of 34 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CLSK as a result. In 73 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.
The Moving Average Convergence Divergence Histogram (MACD) for CLSK turned negative on September 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 34 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 81%.
The 10-day moving average for CLSK crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 81%.
The 50-day moving average for CLSK moved below the 200-day moving average on October 13, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CLSK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
The Aroon Indicator for CLSK entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 15 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +4.63% 3-day Advance, the price is estimated to grow further. Considering data from situations where CLSK advanced for three days, in 233 of 265 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.
CLSK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 43 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.952) is normal, around the industry mean (3.638). P/E Ratio (-2.315) is within average values for comparable stocks, (8.944). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.809). Dividend Yield (0.000) settles around the average of (7.191) among similar stocks. P/S Ratio (5.397) is also within normal values, averaging (16.763).
The Tickeron Price Growth Rating for this company is 90 (best 1 - 100 worst), indicating slightly worse than average price growth. CLSK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CLSK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
Momentum Indicator for STEX turns negative, indicating new downward trend
STEX saw its Momentum Indicator move below the 0 level on October 01, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 79 similar instances where the indicator turned negative. In 76 of the 79 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Moving Average Convergence Divergence Histogram (MACD) for STEX turned negative on October 01, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 46 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
STEX moved below its 50-day moving average on September 25, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where STEX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
STEX broke above its upper Bollinger Band on September 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for STEX entered a downward trend on September 25, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 14 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +15.87% 3-day Advance, the price is estimated to grow further. Considering data from situations where STEX advanced for three days, in 220 of 255 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 93 (best 1 - 100 worst), indicating slightly worse than average price growth. STEX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.295) is normal, around the industry mean (3.638). P/E Ratio (-0.041) is within average values for comparable stocks, (8.944). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.809). Dividend Yield (0.000) settles around the average of (7.191) among similar stocks. STEX's P/S Ratio (526.316) is very high in comparison to the industry average of (16.763).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STEX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
CLSK | STEX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 53 | 62 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 65 Fair valued | 99 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 98 | 100 | |
PRICE GROWTH RATING 1..100 | 90 | 93 | |
P/E GROWTH RATING 1..100 | 97 | 9 | |
SEASONALITY SCORE 1..100 | 43 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CLSK's Valuation (65) in the null industry is somewhat better than the same rating for STEX (99) in the Medical Specialties industry. This means that CLSK’s stock grew somewhat faster than STEX’s over the last 12 months.
CLSK's Profit vs Risk Rating (100) in the null industry is in the same range as STEX (100) in the Medical Specialties industry. This means that CLSK’s stock grew similarly to STEX’s over the last 12 months.
CLSK's SMR Rating (98) in the null industry is in the same range as STEX (100) in the Medical Specialties industry. This means that CLSK’s stock grew similarly to STEX’s over the last 12 months.
CLSK's Price Growth Rating (90) in the null industry is in the same range as STEX (93) in the Medical Specialties industry. This means that CLSK’s stock grew similarly to STEX’s over the last 12 months.
STEX's P/E Growth Rating (9) in the Medical Specialties industry is significantly better than the same rating for CLSK (97) in the null industry. This means that STEX’s stock grew significantly faster than CLSK’s over the last 12 months.
| CLSK | STEX | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 86% | 2 days ago 89% |
| Momentum ODDS (%) | 2 days ago 88% | 2 days ago 90% |
| MACD ODDS (%) | 2 days ago 81% | 2 days ago 90% |
| TrendWeek ODDS (%) | 2 days ago 89% | 2 days ago 90% |
| TrendMonth ODDS (%) | 2 days ago 89% | 2 days ago 90% |
| Advances ODDS (%) | about 1 month ago 88% | about 1 month ago 86% |
| Declines ODDS (%) | 9 days ago 88% | 4 days ago 90% |
| BollingerBands ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CLSK’s FA Score shows that 0 FA rating(s) are green while STEX’s FA Score has 1 green FA rating(s).
- CLSK’s FA Score: 0 green, 5 red.
- STEX’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CLSK’s TA Score shows that 4 TA indicator(s) are bullish while STEX’s TA Score has 3 bullish TA indicator(s).
- CLSK’s TA Score: 4 bullish, 7 bearish.
- STEX’s TA Score: 3 bullish, 6 bearish.
Price Growth
CLSK (@Investment Banks/Brokers) experienced а -5.15% price change this week, while STEX (@Investment Banks/Brokers) price change was -14.16% for the same time period.
The average weekly price growth across all stocks in the @Investment Banks/Brokers industry was -4.83%. For the same industry, the average monthly price growth was -16.43%, and the average quarterly price growth was -12.27%.
Reported Earning Dates
CLSK is expected to report earnings on Nov 24, 2026.
STEX is expected to report earnings on Nov 13, 2026.
Industries' Descriptions
@Investment Banks/Brokers (-4.83% weekly)These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.
Advertisement
CLSK and
Correlation & Price change
A.I.dvisor indicates that over the last year, CLSK has been closely correlated with MARA. These tickers have moved in lockstep 84% of the time. This A.I.-generated data suggests there is a high statistical probability that if CLSK jumps, then MARA could also see price increases.
| Ticker / NAME | Correlation To CLSK | 1D Price Change % | ||
|---|---|---|---|---|
| CLSK | 100% | +3.80% | ||
| MARA - CLSK | 84% Closely correlated | +4.14% | ||
| RIOT - CLSK | 84% Closely correlated | +1.82% | ||
| BTBT - CLSK | 80% Closely correlated | +4.67% | ||
| HIVE - CLSK | 77% Closely correlated | +2.78% | ||
| HUT - CLSK | 77% Closely correlated | +3.68% | ||
More | ||||
STEX and
Correlation & Price change
A.I.dvisor indicates that over the last year, STEX has been loosely correlated with KEEL. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if STEX jumps, then KEEL could also see price increases.
| Ticker / NAME | Correlation To STEX | 1D Price Change % | ||
|---|---|---|---|---|
| STEX | 100% | -1.60% | ||
| KEEL - STEX | 35% Loosely correlated | +2.56% | ||
| BTBT - STEX | 34% Loosely correlated | +4.67% | ||
| BMNR - STEX | 33% Loosely correlated | +5.00% | ||
| PWCM - STEX | 32% Poorly correlated | +3.81% | ||
| CLSK - STEX | 32% Poorly correlated | +3.80% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ALIL | 30.07 | 0.37 | +1.24% |
| Argent Focused Small Cap ETF (ALIL) | |||
| PTBD | 18.34 | 0.01 | +0.05% |
| Pacer Trendpilot US Bond ETF (PTBD) | |||
| HFSP | 15.60 | N/A | N/A |
| TradersAI Large Cap Equity & Cash ETF | |||
| BEDY | 29.28 | -0.01 | -0.03% |
| BNY Mellon Enhanced Dividend and Income ETF (BEDY) | |||
| DVYE | 35.06 | -0.09 | -0.26% |
| iShares Emerging Markets Dividend ETF (DVYE) | |||